+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Lewy Body Dementia Clinical Trial Pipeline Highlights - 2019

  • ID: 4774029
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2
This report, Lewy Body Dementia Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Lewy Body Dementia market. It covers emerging therapies for Lewy Body Dementia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Lewy Body Dementia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Lewy Body Dementia pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Lewy Body Dementia pipeline products by the company.

Short-term Launch Highlights:

Find out which Lewy Body Dementia pipeline products will be launched in the US and Ex-US till 2024.

Summary:
  • Lewy Body Dementia phase 3 clinical trial pipeline products
  • Lewy Body Dementia phase 2 clinical trial pipeline products
  • Lewy Body Dementia phase 1 clinical trial pipeline products
  • Lewy Body Dementia preclinical research pipeline products
  • Lewy Body Dementia discovery stage pipeline products
  • Lewy Body Dementia pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Lewy Body Dementia Pipeline by Stages

2. Lewy Body Dementia Phase 3 Clinical Trial Insights

3. Lewy Body Dementia Phase 2 Clinical Trial Insights

4. Lewy Body Dementia Phase 1 Clinical Trial Insights

5. Lewy Body Dementia Preclinical Research Insights

6. Lewy Body Dementia Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Lewy Body Dementia Phase 3 Clinical Trials, 2019
Table 2: Lewy Body Dementia Phase 2 Clinical Trials, 2019
Table 3: Lewy Body Dementia Phase 1 Clinical Trials, 2019
Table 4: Lewy Body Dementia Preclinical Research, 2019
Table 5: Lewy Body Dementia Discovery Stage, 2019

List of Figures:
Figure 1:: Lewy Body Dementia Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Lewy Body Dementia Phase 3 Clinical Trial Highlights, 2019
Figure 3: Lewy Body Dementia Phase 2 Clinical Trial Highlights, 2019
Figure 4: Lewy Body Dementia Phase 1 Clinical Trial Highlights, 2019
Figure 5: Lewy Body Dementia Preclinical Research Highlights, 2019
Figure 6: Lewy Body Dementia Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll